Follow the Cipla Limited stock price and the full management transaction log of the company, a listed equity based in India. Shares are listed on the IN market, under the supervision of SEBI (PIT + SAST). Operating in the Health Care sector, Cipla Limited has logged 35 insider filings. Market capitalisation: €1,184.6bn. The latest transaction was disclosed on 30 September 2025 (Sale). Among the most active insiders: Vidya Prabhakar Rote jointly with Kiran Rote. All data is accessible without an account.
35
Insider Decl.
n/a
Thresholds
€143,568
28 ops.
Buy Volume
€110,623
4 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Cipla Limited Buy (bullish), based on 37 analysts. Average price target: ₹1,512.86.
10Σ signal
Buys €143,568€110,623 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 9,568 of 29,063 companies
60.1
score / 100
Value
41
Quality
79
FCF yld0.7%
Earn yld3.3%
EV/EBITDA18.7x
ROE12%
Gross mgn62%
Net mgn14%
Debt/EBITDA0.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
51,169 shares@ ₹2.000.0000% mcap100.0% of flowEquity SharesSEBI:d004047ef784c2bb14c2e26db7456af9b5a0ecab
25 of 35 declarations
Acerca de Cipla Limited
Cipla Limited es una empresa farmacéutica india que se especializa en la fabricación de medicamentos genéricos y productos para el cuidado de la salud. Cotiza en la Bolsa de Bombay bajo el símbolo XBOM.